Cytotoxicity and antitumor activity of the phosphate prodrug of a novel microtubule inhibitor.

被引：0
|
作者：
Houze, J [1 ]
Gergely, J [1 ]
Schwendner, S [1 ]
Hoffman, L [1 ]
Beckmann, H [1 ]
Baichwal, V [1 ]
Roche, D [1 ]
Jaen, J [1 ]
机构：
[1] Tularik Inc, S San Francisco, CA 94080 USA
来源：
CLINICAL CANCER RESEARCH | 1999年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
635
引用
收藏
页码：3857S / 3857S
页数：1
相关论文
共 50 条
  • [21] Oleic sulfate: A novel allosteric lipoxygenase inhibitor.
    Holman, TR
    Mogul, R
    Johansen, E
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U126 - U126
  • [22] A novel thapsigargin prodrug demonstrates antitumor activity against a panel of human cancer xenografts
    Denmeade, Samuel R.
    Rosen, Marc
    LeBeau, Aaron
    Dionne, Craig A.
    Christensen, Soeren B.
    Isaacs, John T.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3604S - 3604S
  • [23] Oleic sulfate: A novel allosteric lipoxygenase inhibitor.
    Holman, TR
    Mogul, R
    Johansen, E
    BIOCHEMISTRY, 2000, 39 (06) : 1545 - 1545
  • [24] Cabazitaxel A Novel Microtubule Inhibitor
    Villanueva, Cristian
    Bazan, Fernando
    Kim, Stefano
    Demarchi, Martin
    Chaigneau, Loic
    Thiery-Vuillemin, Antoine
    Nguyen, Thierry
    Cals, Laurent
    Dobi, Erion
    Pivot, Xavier
    DRUGS, 2011, 71 (10) : 1251 - 1258
  • [25] CabazitaxelA Novel Microtubule Inhibitor
    Cristian Villanueva
    Fernando Bazan
    Stefano Kim
    Martin Demarchi
    Loïc Chaigneau
    Antoine Thiery-Vuillemin
    Thierry Nguyen
    Laurent Cals
    Erion Dobi
    Xavier Pivot
    Drugs, 2011, 71 : 1251 - 1258
  • [26] Characterization and antitumor activity of triethylene tetramine, a novel telomerase inhibitor
    Liu, Jianhui
    Guo, Lixia
    Yin, Fei
    Zheng, Xuxu
    Chen, Gang
    Wang, Yun
    BIOMEDICINE & PHARMACOTHERAPY, 2008, 62 (07) : 480 - 485
  • [27] Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity
    Kridel, SJ
    Axelrod, F
    Rozenkrantz, N
    Smith, JW
    CANCER RESEARCH, 2004, 64 (06) : 2070 - 2075
  • [28] The antitumor activity and immumodulatory effect of a novel phosphodiesterase 10 inhibitor
    Gazi, Md Yeashin
    Brandle, Caitlin
    Okoko, Ogacheko
    Chen, Xi
    Keeton, Adam
    Maxuitenko, Yulia
    Piazza, Gary
    Zhou, Gang
    CANCER RESEARCH, 2022, 82 (12)
  • [29] Herbacetin Is a Novel Allosteric Inhibitor of Ornithine Decarboxylase with Antitumor Activity
    Kim, Dong Joon
    Roh, Eunmiri
    Lee, Mee-Hyun
    Oi, Naomi
    Lim, Do Young
    Kim, Myoung Ok
    Cho, Yong-Yeon
    Pugliese, Angelo
    Shim, Jung-Hyun
    Chen, Hanyong
    Cho, Eun Jin
    Kim, Jong-Eun
    Kang, Sun Chul
    Paul, Souren
    Kang, Hee Eun
    Jung, Ji Won
    Lee, Sung-Young
    Kim, Sung-Hyun
    Reddy, Kanamata
    Yeom, Young Il
    Bode, Ann M.
    Dong, Zigang
    CANCER RESEARCH, 2016, 76 (05) : 1146 - 1157
  • [30] Characterization of a Novel PERK Kinase Inhibitor with Antitumor and Antiangiogenic Activity
    Atkins, Charity
    Liu, Qi
    Minthorn, Elisabeth
    Zhang, Shu-Yun
    Figueroa, David J.
    Moss, Katherine
    Stanley, Thomas B.
    Sanders, Brent
    Goetz, Aaron
    Gaul, Nathan
    Choudhry, Anthony E.
    Alsaid, Hasan
    Jucker, Beat M.
    Axten, Jeffrey M.
    Kumar, Rakesh
    CANCER RESEARCH, 2013, 73 (06) : 1993 - 2002
12345